Introduction: Persistently high HIV incidence among women, especially adolescent girls and young women (AGYW), have drawn the attention of national policymakers, donors, and implementers in Sub-Saharan Africa to the integration of HIV and family planning (FP) programs. According to several research studies, FP services could offer a holistic strategy to address the HIV and FP needs of this demographic by including HIV prevention approaches, particularly HIV pre-exposure prophylaxis. Our study set out to explore the obstacles and opportunities that AGYW faced in accessing, using, and continuing HIV prevention and contraceptive services; to develop ideas for novel service models that would allow AGYW to receive integrated, HIV prevention and contraception services; and to evaluate the viability, scalability, and acceptability of these models through dialogues with stakeholders using a human-centered design approach.
Methods: We conducted 128 in-depth interviews with 60 AGYW, 24 public and private health care providers, 10 community leaders, and 10 policymakers). We also conducted two co-creation workshops with 50 AGYW and 10 health care providers in Masaka and Nakasongola districts to generate service delivery models.
Results: Our findings reveal various enablers and barriers to the successful integration of HIV prevention into FP services in the areas of policy, human resources and infrastructure, resource management, service delivery, community involvement, supply chain management, and monitoring and reporting.
Discussion: Successful integration will require addressing key concerns raised by participants in human resource and infrastructure, resource management, service delivery, demand creation, male involvement, supply chain management and monitoring and reporting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891223 | PMC |
http://dx.doi.org/10.3389/frph.2025.1441829 | DOI Listing |
Transfusion
March 2025
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Data from the National Blood Collection and Utilization Survey (NBCUS) suggest a stabilization in blood collections and transfusions following years of decline. Data from the 2023 NBCUS were analyzed to further understand national trends in US blood availability.
Study Design And Methods: In February 2024, all community-based (53) and hospital-based (104) blood collection centers, and a sample of transfusing hospitals were surveyed.
AIDS Care
March 2025
Division of General Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Older people with HIV (OPWH) have an increased risk of type 2 diabetes mellitus (T2DM). Understanding this is important to screen and initiate treatments. This study explored awareness of T2DM, perceived risk, and willingness to receive T2DM preventive education.
View Article and Find Full Text PDFHealth Sci Rep
March 2025
Grupo de Bibliometría, Evaluación de evidencia y Revisiones Sistemáticas (BEERS), Human Medicine Career Universidad Cientifica del Sur Lima Peru.
Background And Aim: HIV attacks the immune system, leading to AIDS if untreated. Mpox, a zoonotic disease like smallpox, is less severe but poses higher risks for immuno-compromised individuals, especially those with HIV. Effective prevention and treatment are crucial.
View Article and Find Full Text PDFFront Reprod Health
February 2025
PATH, Primary Health Care, Geneva, Switzerland.
Introduction: Persistently high HIV incidence among women, especially adolescent girls and young women (AGYW), have drawn the attention of national policymakers, donors, and implementers in Sub-Saharan Africa to the integration of HIV and family planning (FP) programs. According to several research studies, FP services could offer a holistic strategy to address the HIV and FP needs of this demographic by including HIV prevention approaches, particularly HIV pre-exposure prophylaxis. Our study set out to explore the obstacles and opportunities that AGYW faced in accessing, using, and continuing HIV prevention and contraceptive services; to develop ideas for novel service models that would allow AGYW to receive integrated, HIV prevention and contraception services; and to evaluate the viability, scalability, and acceptability of these models through dialogues with stakeholders using a human-centered design approach.
View Article and Find Full Text PDFFront Cell Infect Microbiol
March 2025
Department of AIDS Research, Hebei Key Laboratory of Pathogen and Epidemiology of Infectious Disease, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Background: HIV-1 protease (PR)-reverse transcriptase (RT) inhibitors as national free antiretroviral drugs have been used for 20 years. Integrase strand transfer inhibitors (INSTIs) have been conditionally used as a component of HIV/AIDS treatment regimens in recent years. However, the systematic investigation on the changes in primary drug resistance (PDR) in Hebei province, China was limited.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!